Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FXRV8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 19, 2025. The contract calls for the delivery of Stelara 90 mg/ml syringes and is expected to be completed by October 10, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market leveraging its established capabilities as a federal pharmaceutical supplier.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which holds a ceiling value of $499,999,999 and remains valid through November 2026. The underlying contract enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Stelara, a biologic immunosuppressant medication, represents one component of the extensive pharmaceutical portfolio available through this vehicle, which has established DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FXRV8?
SPE2DB25FXRV8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FXRV8 worth?
The government has obligated $16,250 on SPE2DB25FXRV8.
Is contract SPE2DB25FXRV8 an order under another contract?
Yes. SPE2DB25FXRV8 is a delivery order under SPE2DB24D9131, an indefinite delivery contract.
Was contract SPE2DB25FXRV8 competed?
The extent of competition for SPE2DB25FXRV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award